Back

Pharma

Inhalation & Respiratory Drug Live Event

  • 8th October 2020
  • Zoom flag Zoom
  • ONLINE

This live event will cover a broad spectrum of topics, including an overview and emerging trends of inhalation and respiratory drug products, formulation of inhaled therapies, digital health and patients’ perception, expectation, and intuitiveness in inhaled therapeutics. 

Register today and request the brochure to discover scheduled Inhalation and respiratory drug topics. 

Read more

About Inhalation & Respiratory Drug Event 

Register today and request the brochure to discover scheduled Inhalation and respiratory drug topics. This live event brings together experts from pharmaceutical and biotech industries and manufacturers, academia, and regulatory agencies, with the highest level of expertise in the respiratory field. 

Who should attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Principal Scientists, Chemists and Engineers specializing in:   

  • Connective Health 
  • Device Engineering & Design 
  • Drug Delivery 
  • E-health Inhalation 
  • Formulation Development  
  • Generics & Respiratory  
  • Inhaled Dosage Systems 
  • Marketing & Business Development  
  • Medical Devices & Injectors  
  • New Delivery Technologies  
  • Particles Characterisation  
  • Process Development 
  • Product Development  
  • Pulmonary Pharmacology & Therapeutics 
  • QA/QC 
  • R&D 
  • Regulatory Affairs 
  • Respiratory Drug Development & Manufacturing 
  • Respiratory Medicines 
  • Respiratory Pharmacology 
  • Risk Management 
  • Scientific Research   

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

KEY PRACTICAL LEARNING POINTS

  • Inhalation and respiratory drug development  

  •  Inhalation drug delivery  

  •  Patients perception   

  •  Digital Health   

  •  Formulation development 

Diana A. Fernandes, PT

Inhaled BioPharmaceutical Development Scientist

Hovione

Diana A. Fernandes holds a MSc Degree in Biological Engineering by Instituto Su­perior Técnico, University of Lisbon, 2015. She joined Hovione in the same year as an Industrial PhD Candidate in collaboration with Faculty of Pharmacy, Uni­versity of Lisbon, specializing in spray dried composite formulations for dry pow­der inhaler delivery of biopharmaceuticals, namely enzymes. Since 2018, Diana has also been working as an Inhaled Biopharmaceutical Formulation Scientist at Hovione R&D Drug Product Development Department, supporting the develop­ment and tech-transfer of Spray Drying and Jet Milling projects of inhalable clini­cal products ranging from small to large molecules, from lab to industrial scales.

She was one of the recipients of the prize for Women in Science at the 22nd Congress of the International Society for Aerosols in Medicine (ISAM), Montreux, Switzerland this year

Univ.-Prof. Dr Sven Stegemann, DE

Professor for Patient Centric Drug Development & Manufacturing

Graz University of Technology

Prof. Dr. Sven Stegemann is professor of patient-centric drug design and manu­facturing at the Graz University of Technology, Austria. Sven has worked over the course of 22 years for Capsugel, acting as an advisor to major pharmaceutical companies on ways to improve the design, development and manufacture of pharmaceutical products so they better address the individual needs of patients. In his academic role, Sven focusses his research on the rational development of patient-centric drug products and their associated manufacturing technologies, as well as education and training of students and young scientists. He is the founder and chair of the AAPS focus group on patient-centric drug development, product design and manufacturing as well as the founder and president of the Geriatric Medicine Society e.V. He recently started the industrial-academic collab­oration partnership Patient Centric Medicine (PaCeMe) to suitable and meaning­ful guidance for patient-centric drug product design. He is the editor of the book “Developing Drug Products in an Aging Society: From Concept to Prescribing”, a multidisciplinary approach towards patient-centric drug development for the older and multimorbid patient populations.

Mark Milton-Edwards, UK

Head of Health Solutions

TEVA

Mark is responsible for the Health Solutions within Digital Health at TEVA Pharmaceuticals. Over ten years with TEVA and prior to that, sixteen with AstraZeneca. Mark has held various positions, including R&D Project Leader, VP Sales & Marketing, Strategic Planning & Business Development, and Global Brand Lead. Graduated in Aeronautical Sciences and completed his MBA at Durham University, UK. During his career, he has led technology & especially inhaler development teams through engineering, CMC characterisation, clinical evidence generation, registration within US, EU, and International Markets and, ultimately, to successful global launch. Total Brand Leadership value >$2.5bn. Mark has numerous patents granted and pending in electronic communications, sports technologies, inhaled pharmaceutical development, and respiratory physiological function & predictive AI. Mark is the inventor of Digihaler®. The first FDA approved digital inhaler with built-in sensors. 

Dr. Orest Lastow, SE

CTO

Iconovo AB 

Dr. Orest Lastow is the CTO of Iconovo AB. He is also the co-founder, former CEO of Iconovo. He is responsible for the development of Iconovo’s inhalation platforms. He is also the founder and previous CEO of the Medicon Valley Inhalation Consortium, MVIC AB. Orest was with AstraZeneca for over 15 years and is the principal inventor of AstraZeneca’s new dry powder inhalation platform. He is the author of a textbook on atomization, many journal publications, book contributions, and patent applications. 

Diana A. Fernandes, PT

Inhaled BioPharmaceutical Development Scientist

Hovione

Univ.-Prof. Dr Sven Stegemann, DE

Professor for Patient Centric Drug Development & Manufacturing

Graz University of Technology

Mark Milton-Edwards, UK

Head of Health Solutions

TEVA

Dr. Orest Lastow, SE

CTO

Iconovo AB 

What our
participants
are saying

“Very interesting summit about inhalation and respiratory drug products in Vienna.” 

1
2
3
4
5

Patrick Goncalves

Inhalation Technology

"The presentations covered a wide range of topics and yet were all connected by our common research interests. I learned a great deal and appreciated this opportunity to participate in the 3rd Annual Inhalation & Respiratory Drug Products Summit. ” 

1
2
3
4
5

Ignasi Escamilla

Ferrer

Beyond my expectations! It was very insightful experience thanks to all the knowledgeable speakers. “ 

1
2
3
4
5

Live Event

Attendee